XML 15 R4.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions
3 Months Ended 9 Months Ended
Apr. 03, 2026
Mar. 28, 2025
Apr. 03, 2026
Mar. 28, 2025
Income Statement [Abstract]        
Revenue, net $ 5,950,000,000 $ 1,695,000,000 $ 11,283,000,000 $ 5,454,000,000
Cost of revenue 1,288,000,000 1,313,000,000 4,393,000,000 3,740,000,000
Gross profit 4,662,000,000 382,000,000 6,890,000,000 1,714,000,000
Operating expenses:        
Research and development 337,000,000 285,000,000 980,000,000 847,000,000
Selling, general and administrative 161,000,000 139,000,000 479,000,000 411,000,000
Goodwill impairment 0 1,830,000,000 0 1,830,000,000
Loss on debt extinguishment 46,000,000 0 46,000,000 0
Business separation costs 7,000,000 9,000,000 25,000,000 50,000,000
Employee termination and other 0 0 (2,000,000) 5,000,000
(Gain) loss on business divestiture 0 0 10,000,000 (34,000,000)
Total operating expenses 551,000,000 2,263,000,000 1,538,000,000 3,109,000,000
Operating income (loss) 4,111,000,000 (1,881,000,000) 5,352,000,000 (1,395,000,000)
Interest and other income (expense):        
Interest income 12,000,000 6,000,000 40,000,000 11,000,000
Interest expense (6,000,000) (16,000,000) (71,000,000) (22,000,000)
Other income (expense), net (10,000,000) (10,000,000) (153,000,000) (55,000,000)
Total interest and other income (expense), net (4,000,000) (20,000,000) (184,000,000) (66,000,000)
Income (loss) before taxes 4,107,000,000 (1,901,000,000) 5,168,000,000 (1,461,000,000)
Income tax expense 492,000,000 32,000,000 638,000,000 157,000,000
Net income (loss) $ 3,615,000,000 $ (1,933,000,000) $ 4,530,000,000 $ (1,618,000,000)
Net income (loss) per common share:        
Basic (in dollars per share) $ 24.43 $ (13.33) $ 30.82 $ (11.16)
Diluted (in dollars per share) $ 23.03 $ (13.33) $ 29.42 $ (11.16)
Weighted average shares outstanding:        
Basic (in shares) 148 145 147 145
Diluted (in shares) 157 145 154 145